Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic purine nucleoside analog belonging to the class of purine 2'-deoxyribonucleosides. It features a modified adenosine core with a (3,5-dimethoxybenzoyl)amino group at the 2' position and an N-substitution with (1R)-1,2,3,4-tetrahydro-1-naphthalenyl. The molecule has been cataloged as an experimental small molecule and does not have any approved medical indications or known clinical use. Its mechanism of action is not described in public databases; it may be used primarily for research purposes related to nucleic acid chemistry or as a biochemical probe[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2'-Deoxy-2'-[(3,5-dimethoxybenzoyl)amino]-N-[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]adenosine.